Other OTC Pharmaceuticals (Pharmacies) - Northern Africa

  • Northern Africa
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$0.42bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.39%, resulting in a market volume of US$0.45bn by 2029.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$1.62 are generated in 2024.

Key regions: France, Australia, India, South Korea, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Northern Africa is experiencing steady growth due to various factors. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to the development of this market. Customer preferences in Northern Africa play a significant role in the growth of the Other OTC Pharmaceuticals (Pharmacies) market. Consumers in this region tend to rely heavily on over-the-counter medications for the treatment of common ailments. This preference for self-medication drives the demand for OTC pharmaceuticals in pharmacies. Additionally, consumers in Northern Africa often prioritize convenience and accessibility when it comes to purchasing medication, making pharmacies a popular choice. Trends in the market also contribute to the growth of the Other OTC Pharmaceuticals (Pharmacies) market in Northern Africa. One notable trend is the increasing awareness and adoption of preventive healthcare measures. As more people in the region become proactive about their health, the demand for OTC pharmaceuticals, such as vitamins and supplements, is on the rise. Additionally, the growing aging population in Northern Africa creates a demand for OTC medications that cater to age-related health concerns. Local special circumstances further influence the development of the Other OTC Pharmaceuticals (Pharmacies) market in Northern Africa. The region's healthcare infrastructure, including the availability of healthcare professionals and access to healthcare facilities, plays a crucial role in shaping the market. Limited access to healthcare services in some areas may lead to an increased reliance on pharmacies for basic healthcare needs. Furthermore, cultural beliefs and practices in Northern Africa may influence the types of OTC pharmaceuticals that are in demand. Underlying macroeconomic factors also contribute to the growth of the Other OTC Pharmaceuticals (Pharmacies) market in Northern Africa. Economic stability and growth in the region allow for increased consumer spending on healthcare products. Additionally, government initiatives to improve healthcare access and affordability can stimulate the demand for OTC pharmaceuticals. The presence of a robust pharmaceutical industry in the region also supports the growth of the market. In conclusion, the Other OTC Pharmaceuticals (Pharmacies) market in Northern Africa is developing due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The preference for self-medication, increasing awareness of preventive healthcare, and convenience of pharmacies contribute to the growth of the market. Factors such as limited access to healthcare services, cultural beliefs, economic stability, and government initiatives also play a role in shaping the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)